EILSF exits Sutures India with 3.2x returns as CX Partners buys stake for $37M
Life Sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund) has exited Sutures India Private Limited with cash on cash returns of 3.2x on its three-year-old investment, according to a top official. EILSF sold its stake...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.